USANA Health Sciences, Inc. (NYSE: USNA) is a Consumer Defensive company (Packaged Foods) with a market capitalization of $251M. The Maz Rating grades it against the other companies in its sector.
USANA Health Sciences, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $13.57, USANA Health Sciences, Inc. trades at 0.3x sales and 0.5x book value, with an EV/EBITDA of 2.1. Over the last twelve months it generated about $905M of revenue and a net loss of $21M. It runs a gross margin of 77.3%, an operating margin of 1.1% and a net margin of -2.3%. It shows return on equity of -4.0%, return on invested capital of 1.6% and a free cash flow yield of 11.7%. On the balance sheet: a debt-to-equity ratio of 0.00 and a current ratio of 2.59. Over the past 52 weeks the share price ranged from $12.53 to $23.59, with a beta of 0.67.
USANA Health Sciences, Inc. does not currently pay a dividend.
8 Wall Street analyst ratings cover the stock: 2 Buy, 5 Hold and 1 Sell, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
It depends on the standard you follow. As of October 2026, USANA Health Sciences, Inc. (USNA) passes 2 of 5 published Shariah screening standards checked by Maz Vantage: it passes MSCI and FTSE, and fails AAOIFI, S&P Global and Dow Jones.
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 0.00% / 30% · (Cash+Inv) / Mkt Cap (36m) 67.6% / 30% · Interest income / Revenue 0.31% / 5% | Fail |
| S&P Global | Debt / Mkt Cap (36m) 0.00% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 67.6% / 33% · Receivables / Mkt Cap (36m) 1.90% / 49% · Interest income / Revenue 0.31% / 5% | Fail |
| Dow Jones | Debt / Mkt Cap (24m) 0.00% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 67.6% / 33.33% · Receivables / Mkt Cap (24m) 1.90% / 33.33% · Interest income / Revenue 0.31% / 5% | Fail |
| MSCI | Debt / Avg Assets (4Q) 0.97% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 23.1% / 33.33% · Receivables / Avg Assets (4Q) 0.94% / 33.33% · Interest income / Revenue 0.31% / 5% | Pass |
| FTSE | Debt / Total Assets 0.00% / 33.33% · (Cash+ST Inv) / Total Assets 25.3% / 33.33% · (Cash+Recv) / Total Assets 26.0% / 33.33% · Interest income / Revenue 0.31% / 5% | Pass |
It depends on the standard you follow. As of October 2026, USANA Health Sciences, Inc. (USNA) passes 2 of 5 published Shariah screening standards checked by Maz Vantage: it passes MSCI and FTSE, and fails AAOIFI, S&P Global and Dow Jones.
No. USANA Health Sciences, Inc. is over the AAOIFI limit on (Cash+Inv) / Mkt Cap (36m).
About 0.31% of each dividend: USANA Health Sciences, Inc.'s interest income as a share of its revenue. Give that share to charity; the dividend purification calculator works it out per holding.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated October 3, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.